(Total Views: 422)
Posted On: 05/18/2025 6:41:02 PM
Post# of 157707
MRK is my suspect, I’ve been doing a pattern of life on them….
Merck’s Cash Power:
With $15.5B in Q1 2025 revenue and a robust balance sheet, Merck can afford to take risks on speculative assets.
I’m watching them.
Merck’s Cash Power:
With $15.5B in Q1 2025 revenue and a robust balance sheet, Merck can afford to take risks on speculative assets.
I’m watching them.
(10)
(0)
Daniel Rizzo
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
— Jeremiah 51:36
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
— Jeremiah 51:36
